Skip to content
Genetic Analysis
Genetic Analysis
  • Home
  • About us
    • How we work
    • Management
    • Board of Directors
    • Partnerships
  • Products
    • Service Products
      • The GA-map® Dysbiosis Test Lx
      • The GA-map® COVID-19 Fecal Test Kit
    • Lab Products
      • The GA-map® Dysbiosis Lx reagent kit
      • The GA-map® COVID-19 reagent kit
  • News
    • Press Releases
    • News
  • Investors
    • Investor News
      • Press Releases
    • Financial Reports
    • Financial Calendar
    • Share Information
    • IPO 2021
    • Corporate Governance
    • Primary Insiders
    • IR Contacts
  • Order
  • Contact us
Genetic Analysis
  • Home
  • About us
    • How we work
    • Management
    • Board of Directors
    • Partnerships
  • Products
    • Service Products
      • The GA-map® Dysbiosis Test Lx
      • The GA-map® COVID-19 Fecal Test Kit
    • Lab Products
      • The GA-map® Dysbiosis Lx reagent kit
      • The GA-map® COVID-19 reagent kit
  • News
    • Press Releases
    • News
  • Investors
    • Investor News
      • Press Releases
    • Financial Reports
    • Financial Calendar
    • Share Information
    • IPO 2021
    • Corporate Governance
    • Primary Insiders
    • IR Contacts
  • Order
  • Contact us

Financial Reports

Genetic Analysis AS is reporting according to IFRS. The financial reports published by Genetic Analysis AS in reverse chronological order are:

Interim Report Q3 2021Download
Interim Report H1 2021Download
Annual Report 2020Download

Annual Report 2019Download
Annual Report 2018Download

Genetic Analysis AS is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients.

Contact

Phone: +47 48 32 16 10
E-mail: info@genetic-analysis.com
Address: Genetic Analysis AS, Kabelgata 8
0580 Oslo, Norway

Open Google Maps
Connect

LinkedIn

Facebook

Twitter

Navigate

Contact Us

Terms of Use

Privacy Policy

© 2021 Genetic Analysis

  • Home
  • About us
    • How we work
    • Management
    • Board of Directors
    • Partnerships
  • Products
    • Service Products
      • The GA-map® Dysbiosis Test Lx
      • The GA-map® COVID-19 Fecal Test Kit
    • Lab Products
      • The GA-map® Dysbiosis Lx reagent kit
      • The GA-map® COVID-19 reagent kit
  • News
    • Press Releases
    • News
  • Investors
    • Investor News
      • Press Releases
    • Financial Reports
    • Financial Calendar
    • Share Information
    • IPO 2021
    • Corporate Governance
    • Primary Insiders
    • IR Contacts
  • Order
  • Contact us